Regeneron has received an US Food and Drug Administration (FDA) rejection for a new blood cancer therapy and expects separate ...

Just days after telling AstraZeneca how proud he was at its $50 billion investment strategy for the US, President Donald ...

Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific ...

A 19-year-old Slovakian student won $100,000 for his idea to make the antiviral drug, galidesivir, out of corn waste.

While the broader stock market suffered steep losses amid trade policy shifts select health technology equities stood out.

Local pharma stocks were rocky on Friday after President Donald Trump directed major drugmakers to reduce the cost of their ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Tarrytown-based Regeneron Pharmaceuticals has reported financial results for its second quarter of 2025. Net revenues increased 4% from the $3.54 ...

The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...

The pharmaceutical industry has long protested the idea of globally linked drug prices as a threat to years of U.S. dominance ...

Second Quarter 2025 Results Key Financial Results Revenue: US$3.68b (up ...